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The G2 fusion subunit of the Junı´n virus envelope glycoprotein GP-C contains two hydrophobic heptad-repeat regions that are postulated to
form a six-helix bundle structure required for the membrane fusion activity of Class I viral fusion proteins. We have investigated the role of these
heptad-repeat regions and, specifically, the importance of the putative interhelical a and d position sidechains by using alanine-scanning
mutagenesis. All the mutant glycoproteins were expressed and transported to the cell surface. Proteolytic maturation at the subtilisin kexin
isozyme-1/site-1-protease (SKI-1/S1P) cleavage site was observed in all but two of the mutants. Among the adequately cleaved mutant
glycoproteins, four positions in the N-terminal region (I333, L336, L347 and L350) and two positions in the C-terminal region (R392 and W395)
were shown to be important determinants of cell–cell fusion. Taken together, our results indicate that a-helical coiled-coil structures are likely
critical in promoting arenavirus membrane fusion. These findings support the inclusion of the arenavirus GP-C among the Class I viral fusion
proteins and suggest pharmacologic and immunologic strategies for targeting arenavirus infection and hemorrhagic fever.
D 2005 Elsevier Inc. All rights reserved.Keywords: Arenavirus; Junı´n virus or Argentine hemorrhagic fever virus; Envelope glycoprotein; GP-C; Membrane fusion; Six-helix bundle; MutagenesisIntroduction
Arenaviruses are endemic in rodent populations worldwide
(Salazar-Bravo et al., 2002) and are transmitted to humans by
exposure to infected animals. Infection by Old World
arenaviruses such as Lassa virus, or New World species such
as the South American group including Junı´n, Machupo and
Guanarito viruses, are responsible for recurring and emerging
outbreaks of viral hemorrhagic fevers with high mortality
(McCormick and Fisher-Hoch, 2002; Peters, 2002). Prophy-
lactic and therapeutic options to combat arenavirus infection
are limited, and the development of effective immunogens and
antiviral agents to interfere with arenavirus entry may have
broad public health benefits.0042-6822/$ - see front matter D 2005 Elsevier Inc. All rights reserved.
doi:10.1016/j.virol.2005.08.030
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victor@biol.unlp.edu.ar (V. Romanowski), jack.nunberg@umontana.edu
(J.H. Nunberg).The arenaviruses are enveloped bisegmented RNA viruses
whose genome consists of two single-stranded RNA molecules
(Buchmeier et al., 2001; Clegg et al., 2000). During biogenesis,
arenaviral particles assemble and bud at the plasma membrane.
The mature envelope glycoprotein complex of the arenavirus
consists of three noncovalently associated subunits derived
from the GP-C precursor by proteolytic cleavage events: a
stable myristoylated 58 amino-acid signal peptide (SSP), the
receptor-binding G1 subunit and the transmembrane G2 fusion
protein (Buchmeier, 2002; Eichler et al., 2003; York et al.,
2004). The initial cleavage to yield SSP is likely mediated by
the cellular signal peptidase, and the mature G1 and G2
subunits are subsequently generated by the cellular SKI-1/S1P
protease. Both cleavage events, as well as the presence of the
myristoylated SSP subunit, are required for envelope glyco-
protein-mediated membrane fusion (York et al., 2004). Entry of
virion particles into host cells is initiated by G1 binding to cell
surface receptors followed by endocytosis of the virion into
smooth vesicles (Borrow and Oldstone, 1994). Although a-
dystroglycan serves as a binding receptor for the Old World5) 267 – 274
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major New World group of arenaviruses is unknown (Spiro-
poulou et al., 2002). Membrane fusion is pH-dependent and is
activated upon acidification of the maturing endosome (Borrow
and Oldstone, 1994; Castilla et al., 1994; Di Simone and
Buchmeier, 1995; Di Simone et al., 1994).
The molecular basis for envelope glycoprotein-mediated
membrane fusion in the arenaviruses is largely unknown,
however, sequence analysis of the G2 ectodomain of Lassa
virus and lymphocytic choriomeningitis virus (LCMV) has
revealed two heptad-repeat regions that can be represented to
form amphipathic helices (Gallaher et al., 2001). This sequence
motif is found among the large group of viral envelope
glycoproteins that promote membrane fusion through the
formation of a fusion-active core structure comprising a stable
bundle of six a-helices. These Class I fusion proteins include
those of the retroviruses, orthomyxoviruses, paramyxoviruses,
filoviruses and coronaviruses. In these proteins, the six-helix
bundle structure involves a central coiled coil, formed by N-
terminal heptad-repeat regions of the trimeric fusion subunit
ectodomain, surrounded by three anti-parallel helices of the C-
terminal heptad repeats which bind to the conserved hydro-
phobic grooves on the coiled-coil surface. Formation of this
thermodynamically favored six-helix bundle brings the viral
and cell membranes into apposition and is thought to provide
the driving energy to initiate membrane fusion (Earp et al.,
2005; Eckert and Kim, 2001; Hughson, 1997; Weissenhorn et
al., 1999 and references therein). In keeping with the proposal
that the arenavirus G2 ectodomain might also form a fusion-
active six-helix bundle, Gallaher and colleagues have shown
that a synthetic peptide derived from the N-terminal heptad-
repeat region of LCMV is able to assume a-helical content
(Gallaher et al., 2001).
In this report, we have utilized alanine-scanning mutagen-
esis of the heptad-repeat regions of the New World Junı´n
arenavirus envelope glycoprotein to obtain genetic evidence in
support of this model for membrane fusion in the arenaviruses.
We show that mutations at predicted interhelical positions
affect the ability of the envelope glycoprotein complex to
mediate pH-dependent cell–cell fusion. These findings suggest
that membrane fusion by the arenavirus envelope glycoprotein
complex is promoted via a refolding into a highly stable six-
helix bundle structure characteristic of Class 1 viral fusion
glycoproteins.
Results and discussion
Sequence analysis of the G2 ectodomain of the Junı´n
arenavirus
The amino acid sequences of the heptad repeats of New
World and Old World arenaviruses were aligned to demonstrate
the high degree of conservation within the family (Fig. 1A).
One key consideration in assigning a register to the proposed
helical coiled coil of the heptad repeats (i.e., positions a
through g) was to maximize the degree of hydrophobicity at
the interhelical a and d positions. Upon inspection of thealigned sequences, a unique register of a and d positions was
apparent (Figs. 1A and B). The a and d positions of the
proposed N-terminal helix consist of hydrophobic residues
common to the central interface of a trimeric coiled coil (e.g.,
leucine, isoleucine, methionine and valine). Positions assumed
to lie on the exterior face of the coiled coil (b, c and f
positions) contain polar or charged residues. This pattern is
repeated through the C-terminal heptad-repeat region and
appears to end at the C-terminal-most d and a positions
(K409 and D413, respectively). Hydrophilic residues at two a
positions in the New World viruses (R392 and S399) are
replaced by less polar amino acids in the Old World viruses
(serine and alanine, respectively). The hydrophilic sidechains,
if buried, may impart specificity to the process of coiled-coil
folding at the expense of thermal stability (Ji et al., 2000; Lumb
and Kim, 1995).
Expression of Junı´n virus envelope glycoproteins bearing
alanine mutations at a and d positions
To investigate the proposed a-helical structures and their
role in promoting membrane fusion in the arenaviruses, we
subjected the heptad-repeat regions of the Junı´n virus envelope
glycoprotein to scanning mutagenesis. Each a and d position
amino acid was individually changed to alanine, a small
residue that is a good helix inducer yet contributes little to the
hydrophobic forces that predominantly stabilize coiled-coil
structures. Alanine substitutions at these positions are likely to
alter the stability of the proposed six-helix bundle, but not to
disrupt its overall folding. We anticipated that alanine muta-
tions at interhelical positions within the coiled-coil bundle may
selectively affect the ability of the envelope glycoprotein to
mediate membrane fusion.
For these studies, we utilized the GP-C gene of the
pathogenic Junı´n virus isolate MC2 (York et al., 2004). The
wild-type and mutant plasmids were introduced in Vero 76
cells, and the envelope glycoproteins were expressed using the
T7 promoter of the plasmid vector and T7 RNA polymerase
provided by infection with the recombinant vaccinia virus
vTF7-3 (Fuerst et al., 1986). Cultures were metabolically
labeled and subsequently solubilized. The envelope glycopro-
teins were immunoprecipitated using the mouse MAb BF11
(Sanchez et al., 1989) directed to the G1 subunit (York et al.,
2004).
We have previously shown that the Junı´n virus envelope
glycoprotein complex isolated by immunoprecipitation retains
the three noncovalently associated subunits: the mature G1
and G2 glycoproteins as well as the stable signal peptide, SSP
(York et al., 2004 and see Fig. 2). Cleavage by signal
peptidase and the SKI-1/S1P protease are incomplete upon
recombinant expression such that two precursor glycoproteins
(full-length GP-C and the G1–G2 precursor lacking SSP) are
observed. The glycoproteins isolated by immunoprecipitation
of the wild-type envelope glycoprotein, and an SKI-1/S1P
cleavage-site mutant (cd-JGPC; York et al., 2004), are
illustrated in Fig. 2A (far left). The two precursor glycopro-
teins migrate with molecular weights of 65 kDa and 60 kDa,
Fig. 1. Schematic representation of the Junı´n virus GP-C glycoprotein and N- and C-terminal heptad-repeat regions. (A) Amino acids of the Junı´n virus envelope
glycoprotein are numbered from the initiating methionine, and cysteine residues (|) and potential glycosylation sites (Y) are marked. The SSP and SKI-1/S1P
cleavage sites and the resulting SSP, G1 and G2 subunits are indicated. Within G2, the C-terminal transmembrane (TM) and cytoplasmic (cyto) domains are shown,
as are the N- and C-terminal heptad-repeat regions (light gray shading). A comparison of heptad-repeat sequences among arenavirus species is detailed below.
Sequences include the New World isolates Junı´n (D10072), Tacaribe (M20304), Machupo (AY129248) and Guanarito (AAN05423) and Old World isolates Lassa-
Josiah (M15076), Mopeia (M33879), LCMV-Armstrong (M20869). The 3,4 periodicity of a and d heptad-repeat positions is indicated by shading. (B) Helical wheel
projections of proposed heptad-repeat periodicity. Amino acids shown above are listed in numeric order at a –g positions. A schematic of a six-helix bundle is at the
lower right, and the details of the canonical interhelical packing arrangement are illustrated.
Fig. 2. Expression of wild-type and mutant envelope glycoproteins. (A) Metabolically labeled glycoproteins were immunoprecipitated using the G1-specific MAb
BF11 and separated on NuPAGE 4–12% Bis–Tris gels. The wild-type (wt) and SKI-1/S1P cleavage-defective (cd) glycoproteins are shown for comparison with the
N- and C-terminal heptad-repeat mutants. V326A indicates the glycoprotein in which V326 has been changed to alanine. The two bands labeled GP-C (i.e., the full-
length GP-C and the G1–G2 precursor lacking SSP) as well as the heterodisperse smear of G1 are better resolved following deglycosylation using PNGase F (B).
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35 kDa, whereas the heterogeneous smear of the G1
glycoprotein is difficult to discern. These bands are better
resolved following deglycosylation using peptide:N-glycosi-
dase F (PNGase F) (Fig. 2B, far left). The G1 and G2 subu-
nits are absent in the cleavage-defective cd-JGPC envelope
glycoprotein.
Among the seventeen N- and C-terminal heptad-repeat
mutants, all the GP-C glycoproteins were expressed, and all
were cleaved by signal peptidase to generate the 5 kDa SSP
(Fig. 2A). The relative efficiencies of SKI-1/S1P protease
cleavage, however, varied among the mutants (Figs. 2A and B).
In some mutants (e.g., Y385A and L402A), SKI-1/S1P
cleavage was undetectable, similar to that in the cleavage-
site-defective envelope glycoprotein. In other mutants, the
amounts of cleavage ranged from markedly reduced to levels
greater than those in the wild-type. To quantitate the relative
extents of SKI-1/S1P processing, we determined the amount of
radioactivity present in the deglycosylated GP-C precursors
and in the mature G1 and G2 polypeptides using a Fuji 3000-G
phosphorimager and Image Gauge software (Fuji). Our
analysis of two independent experiments is shown in Fig. 3.
Several classes of mutants could be defined by this
analysis. Proteolytic maturation was essentially absent in the
Y385A and L402A mutants and significantly reduced in
L350A and W395A (30 and 45% of wild-type levels,
respectively). Other mutants were cleaved much as the wild-
type glycoprotein (L336A, N340A, I388A, R392A, S399A,
M406A and K409A; from 65 to 100% of wild-type levels),
whereas several mutations in the N-terminal heptad-repeatFig. 3. Quantitation of SKI-1/S1P cleavage and the formation of the mature G1
and G2 subunits. Phosphorimages of the deglycosylated polypeptides
represented in Fig. 1B were analyzed using Image Gauge software (Fuji) and
the Profile and Background tools to quantitate the radioactivity (PSL units).
The efficiency of SKI-1/S1P cleavage was defined as the ratio of PSL units in
the sum of the G1 + G2 peaks relative to the total number in both GP-C and
G1 + G2 peaks. Results were analyzed for two complete experiments, and the
relative conclusions are consistent with those of additional partial studies.
Because the absolute efficiency of cleavage varied between experiments, each
experiment was normalized to the average extent of cleavage in the entire 19-
member panel. This average ratio (16% and 24% in the two complete
experiments shown here) was used to determine the relative degree of cleavage
in each mutant, and these numbers were averaged to generate the values
plotted. By this analysis, the wild-type envelope glycoprotein was cleaved
1.17-fold better than the arbitrary average of the panel; 100% and 50% of the
wild-type level are shown as dashed lines. Error bars represent T one standard
deviation.region appeared to enhance proteolytic cleavage up to 2-fold
(V326A, M329A, I333A, M343A and I347A). Shedding of
the mature G1 subunit into the culture supernatant correlated
with the extent of SKI-1/S1P cleavage (not shown). Although
proteolytic processing varied among the mutants, all but two
showed significant cleavage of the G1–G2 precursor.
Transport of the mutant envelope glycoprotein complexes
to the cell surface was determined by flow cytometry using
the G1-specific MAb BE08 (Sanchez et al., 1989). Cells from
cultures transiently transfected to express the wild-type and
cd-JGPC glycoproteins displayed two populations: cells
expressing GP-C (30 fluorescence channel) and those that
escaped transfection (<30 fc) (Fig. 4). Proteolytic maturation
of the arenavirus envelope glycoprotein complex is clearly not
required for transport to the cell surface. In fact, staining of
the cleavage-defective mutant cd-JGPC was generally higher
and more discrete than that of the wild-type envelope
glycoprotein, likely due to shedding of the G1 subunit from
the wild-type but not the cleavage-defective complex (York et
al., 2004). Among the heptad-repeat mutants (Fig. 4), all
patterns of staining were within this range and qualitatively
similar. We conclude that transport of the mutant glycopro-
teins to the cell surface was not markedly affected.
The precise pattern of cell-surface staining is expected to
reflect the degree of transport and the relative extent of G1
shedding. Our efforts to further characterize the surface GP-C
complex biochemically were limited by the refractory nature of
the GP-C complex to covalent modification by standard
biotinylation reagents (unpublished). Overall, however, suc-
cessful entry into the Golgi and transit to the cell surface
suggests that the mutations do not globally perturb the
structural integrity of the mutant GP-C complexes.
Mutations at interhelical positions affect pH-dependent
cell–cell fusion
The effects of the alanine mutations on the ability of the
envelope glycoprotein to mediate pH-dependent cell–cell
fusion were determined in Vero 76 cells using the recombinant
vaccinia virus-based LacZ fusion reporter assay (Nussbaum et
al., 1994) as described (York et al., 2004). In this assay, h-
galactosidase expression initiated by fusion of the effector and
target cells was determined using a chemiluminescent substrate
(GalactoLite Plus, Tropix). The extent of pH-dependent cell–
cell fusion mediated by the wild-type and mutant envelope
glycoproteins is shown in Fig. 5.
Five alanine substitutions at a and d positions reduced
fusogenicity to less than 10% of the wild-type GP-C or
comparably to the SKI-1/S1P cleavage-site mutation in cd-
JGPC: I333A in the N-terminal heptad repeat and Y385A,
R392A, W395A and L402A in the C-terminal heptad repeat
(Fig. 5). Although the lack of proteolytic cleavage in Y385A
and L402A is likely sufficient to account for the defect in
fusion by these mutants, the other glycoproteins (I333A,
R392A and W385A) showed significant levels of cleavage.
Three additional mutations in the N-terminal region (L336A,
I347A and L350A) reduced cell–cell fusion to less than 50%
Fig. 4. Flow cytometric analysis of cell-surface envelope glycoprotein. Vero cells expressing the envelope glycoproteins were stained using the G1-specific
neutralizing MAb BE08 (Sanchez et al., 1989) and subsequently stained using propidium iodide (1 Ag/ml) to exclude dead cells in the population. Cells were fixed
using 2% formaldehyde and analyzed using a FACSCalibur flow cytometer (BD Biosciences). Background staining of mock-transfected cells is shown in the first
panel; the non-expressing cell population within the GP-C transfected cultures (other panels) tend to pick up additional staining, possibly due to membrane exchange
within the culture. The expressing cell populations were defined using a gate of 30 that included <0.1% of the mock-transfected population (arrow).
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of the culture to acidic (pH 5.0) medium.
In some mutants, clear defects in membrane fusion arose
despite wild-type levels of SKI-1/S1P cleavage (viz., I333A
and I347A). In others, it was difficult to determine whether the
deficiencies in cell–cell fusion were directly attributable to the
envelope glycoprotein fusion machinery or to defects in SKI-1/
S1P proteolytic processing. In several examples, mutants
displaying reductions in cleavage efficiency were able to
mediate cell–cell fusion much as the wild-type glycoprotein
(viz., I388A and S399A), whereas other comparably cleavage-
deficient mutants were defective in membrane fusion (viz.,
L336A, L350A and R392A). These observations suggested
that the variable deficiencies in SKI-1/S1P cleavage were not
sufficient to account for the majority of the defects in cell–cell
fusion under our assay conditions.
In order to more fully examine this point, we reconstructed
the variable extents of proteolytic cleavage using mixtures of
the wild-type and SKI-1/S1P cleavage-site mutant plasmids. Inthese studies, we determined the relative efficiencies of SKI-1/
S1P cleavage by PAGE and the extent of pH-dependent
membrane fusion in the recombinant vaccinia virus-based
LacZ fusion reporter assay (Fig. 6). Although the total amount
of envelope glycoprotein remained constant as the wild-type
plasmid was diluted 1:3 and 1:9 with cd-JGPC (90% and 85%
of the undiluted wild-type level, respectively), the relative
amounts of mature G1 and G2 decreased progressively, from
20% to 5% and 2%, respectively. Despite a 90% decrease in
overall SKI-1/S1P cleavage, however, cell–cell fusion was
unaffected. Within these limits, our measurements of cell–cell
fusion appear not to be sensitive to the relative amounts of
proteolytically matured G1 and G2 glycoprotein, and we infer
that mutants in which SKI-1/S1P cleavage is retained to at least
10% of the wild type level can be informative in defining
specific defects in membrane fusion.
Tertiary effects of the heptad-repeat mutations that may
indirectly affect both proteolytic cleavage and fusogenicity,
such as those that influence overall protein folding, trafficking
Fig. 6. Reconstruction to determine the effect of variable SKI-1/S1P cleavage
efficiency on envelope glycoprotein fusogenic potential. Vero 76 cells were
transfected with 4 Ag DNA containing either the wild-type GP-C plasmid (wt),
a 1:3 mixture of the wt and cd-JGPC plasmids, respectively, or a 1:9 mixture of
the same plasmids. Parallel cultures were metabolically labeled and immuno-
precipitated, and PNGase F-treated polypeptides were analyzed as described in
Figs. 2 and 3 (A) or subjected to the recombinant vaccinia virus-based fusion
assay as described in Fig. 5 (B).
Fig. 5. Fusogenic potential of wild-type and mutant envelope glycoproteins. The
ability of the envelope glycoproteins to mediate pH-dependent cell –cell fusion
was detected using the recombinant vaccinia virus-based h-galactosidase
reporter assay (Nussbaum et al., 1994) as described in Materials and methods.
h-galactosidase activity induced upon cell –cell fusion was quantitated using the
chemiluminescent substrate GalactoLite Plus (Tropix). Background levels of
chemiluminescence obtained from cultures treated at neutral pH were subtracted
from the relative light unit (RLU) measurement, and all RLU values were then
normalized to that of the wild-type GP-C control. Error bars represent T one
standard deviation among 6 replicate fusion cultures. All conclusions were
replicated using X-gal staining of parallel co-cultures (York et al., 2004).
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from our simple reconstitution model. In the case of the
cleavage-site defective glycoprotein, these considerations are
likely moot as GP-C biogenesis appears to be otherwise blind
to the SKI-1/S1P site mutation. Among the heptad-repeat
mutants, we also observe no evidence for global defects in
folding, assembly or transport and thereby extend the
interpretation of the model experiment to these glycoproteins.
Thus, we conclude that the following a and d heptad-repeat
positions contribute directly to promoting pH-dependent
membrane fusion by the Junı´n virus envelope glycoprotein:
I333, L336, I347 and L350 in the N-terminal region and R392
and W395 in the C-terminal region.
Arenavirus GP-C is likely a member of the Class I fusion
proteins
Taken together, our studies identify a series of amino acid
residues within the N- and C-terminal heptad-repeat regions of
the G2 ectodomain that impair the ability of the Junı´n virus
envelope glycoprotein to mediate pH-dependent cell–cell
fusion. The residues chosen for mutagenic analysis were
modeled to lie at interhelical a and d positions, in keeping
with the predominant role of these positions for coiled-coil
formation. Alanine substitutions at these positions are often
benign (Luo and Weiss, 1998), and the rich appearance of
fusion-deficient phenotypes among our mutants is consistent
with this model and with the important role of the a-helical
coiled-coil bundle in promoting membrane fusion in the
arenaviruses.
Several of the alanine mutations also affected SKI-1/S1P
cleavage of the G1–G2 precursor glycoprotein, presumably
through conformational effects that otherwise do not perturb
envelope glycoprotein trafficking to the cell surface. These
effects on proteolytic cleavage may signal a distinct role of theheptad-repeat regions in the folding of the native envelope
glycoprotein during biogenesis. Importantly, our studies
suggest that these effects on proteolytic cleavage per se are
unlikely to account for the specific deficiencies in membrane
fusion activity.
These genetic studies provide direct support to the proposal,
originally based on amino acid sequence analysis (Gallaher et
al., 2001), that membrane fusion in the arenaviruses is
promoted by the formation of an a-helical coiled-coil structure
similar to that described in the Class I viral fusion proteins.
Biophysical evidence emerging from the laboratory of M. Lu
(Weill Medical College of Cornell University) confirms that
peptides derived from the N- and C-terminal heptad repeats of
the Junı´n virus G2 associate to form a six-membered trimeric
structure with a high degree of helical content and thermal
stability (unpublished). The precise limits of the N- and C-
terminal a-helices and the details of the interhelical interactions
within the arenavirus six-helix bundle await atomic-level
structure determination.
The inclusion of the arenavirus envelope glycoprotein
within this class of viral fusion proteins suggests several
specific strategies towards the development of vaccines and
therapeutic agents against arenavirus infection. Peptides
derived from the C-terminal helical region of the HIV fusion
protein that are believed to irreversibly interfere with
formation of the six-helix bundle are in clinical use in the
treatment of HIV disease (Kilby et al., 2002), and small
molecule inhibitors may be feasible (Eckert et al., 1999).
Similarly, broadly neutralizing antibodies that target the
membrane-proximal region of the HIV gp41 ectodomain
adjacent to the C-terminal heptad repeat (Muster et al., 1993;
Stiegler et al., 2001; Zwick et al., 2001) may likewise
interfere in this process (Follis et al., 2002). Further structural
and immunochemical studies of the arenavirus envelope
glycoprotein complex may point to conserved mechanisms
and broadly applicable strategies towards the prevention and
treatment of arenaviral hemorrhagic fevers.
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Molecular reagents, recombinant vaccinia viruses and
monoclonal antibodies
The GP-C gene (Ghiringhelli et al., 1991) of the pathogenic
MC2 isolate of the Argentine hemorrhagic fever (Junı´n) virus
was expressed using the bacteriophage T7 polymerase pro-
moter in a pcDNA3.1-based (Invitrogen) expression plasmid
(York et al., 2004). The GP-C gene was modified to express an
innocuous S-peptide (Spep) affinity tag (Kim and Raines,
1993) at the cytoplasmic C-terminus to facilitate manipulations
(York et al., 2004). The h-galactosidase fusion reporter assay
(Nussbaum et al., 1994) was used to assess the ability of the
envelope glycoprotein to mediate receptor-dependent cell–cell
fusion. The recombinant vaccinia virus vCB21R-lacZ expres-
sing h-galactosidase under the control of the T7 promoter
(Nussbaum et al., 1994) was obtained from C. Broder, P.
Kennedy and E. Berger (NIH) through the AIDS Research and
Reference Reagent Program. Mouse monoclonal antibodies
(MAbs) directed to the G1 subunit of GP-C (Sanchez et al.,
1989) were kindly provided by Drs. Tom Ksiasek and Tony
Sanchez (Special Pathogens Branch, CDC, Atlanta).
Expression of GP-C
The envelope glycoprotein was transiently expressed in
Vero 76 cells using the pcDNA3.1-based T7 promoter and the
recombinant vaccinia virus encoding T7 polymerase vTF7-3
(Fuerst et al., 1986). Vero cells were infected with the
recombinant vaccinia virus at a multiplicity of two in
Dulbecco’s Minimal Essential Medium (DMEM) containing
2% fetal bovine serum (FBS). Cytosine arabinoside (araC)
was included at 10 AM to limit vaccinia virus expression
(Hruby et al., 1980). After 30 min, the cells were washed and
transfected with the GP-C expression plasmid using Lipofec-
tamine 2000 reagent (Invitrogen). Metabolic labeling using 32
ACi/ml of [35S]-ProMix (Amersham Pharmacia Biotech) was
initiated 6 h post-transfection in methionine- and cysteine-free
DMEM containing 10% dialyzed FBS and 10 AM araC and
was continued for 12–16 h. Cultures were then washed in
physiological buffered saline (PBS) and lysed using cold
Tris–saline buffer (50 mM Tris–HCl and 150 mM NaCl at
pH 7.5) containing 1% Triton X-100 nonionic detergent and
protease inhibitors (1 Ag/ml each of aprotinin, leupeptin and
pepstatin). A soluble fraction was prepared by centrifugation
at 15,000g for 30 min at 4 -C. The expressed glycoproteins
were isolated either by immunoprecipitation using the G1-
directed MAb BF11 (Sanchez et al., 1989) and Protein A–
Sepharose (Sigma) or by using the C-terminal (G2) Spep
affinity tag and S-protein agarose (Novagen). In some
experiments, the isolated glycoproteins were deglycosylated
using peptide:N-glycosidase F (PNGase F, New England
Biolabs). Glycoproteins and polypeptides were resolved using
NuPAGE 4–12% Bis–Tris gels (Invitrogen) and the recom-
mended sample buffer containing lithium dodecyl sulfate and
reducing agent. Molecular weight markers included [14C]-methylated Rainbow proteins (Amersham Pharmacia Bio-
tech). Radiolabeled proteins were imaged using a Fuji FLA-
3000G imager and analyzed using ImageGauge software
(Fuji).
Flow cytometry
Vero 76 cells transiently expressing the wild-type and
mutant glycoproteins were labeled using the G1-specific
MAb BE08 (Sanchez et al., 1989) and a secondary fluorescein
isothiocyanate (FITC)-conjugated goat anti-mouse antibody
(Jackson ImmunoResearch). Cells were subsequently stained
using propidium iodide (1 Ag/ml) and then fixed in 2%
formaldehyde. Populations were analyzed using a FACSCali-
bur flow cytometer and CellQuest software (BD Biosciences).
Envelope glycoprotein-mediated cell–cell fusion
The h-galactosidase fusion reporter assay (Nussbaum et al.,
1994) was used to assess the ability of the envelope
glycoproteins to mediate receptor-dependent cell–cell fusion.
In these studies, Vero cells infected with vTF7-3 and expressing
the envelope glycoprotein were co-cultured with Vero cells
infected with vCB21R-lacZ, a recombinant vaccinia virus
expressing h-galactosidase under the control of the T7
promoter. These latter (target) cells were obtained by incubat-
ing Vero 76 cells with a multiplicity of two vCB21R-lacZ
plaque-forming units per cell and allowing the infection to
proceed overnight in the presence of 100 Ag/ml of the vaccinia
virus assembly inhibitor, rifampicin. After mixing of the
envelope glycoprotein-expressing and target cells in medium
containing both araC and rifampicin (Hruby et al., 1980; York
et al., 2004), the co-cultures were continued for 5 h prior to
being subjected to a 30 min pulse of neutral or acidic (pH 5.0)
medium as previously described (York et al., 2004). h-
galactosidase expression is induced upon fusion of the effector
and target cells and was detected, after 5 h of continued
cultivation at neutral pH, in cell lysates (Tropix) using the
chemiluminescent substrate GalactoLite Plus (Tropix). Cell–
cell fusion was quantified using a Tropix TR717 microplate
luminometer.
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